Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia
- 1 January 2011
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 105 (02), 295-301
- https://doi.org/10.1160/th10-05-0334
Abstract
Recurrent miscarriage affects 1–2% of women. In more than half of all recurrent miscarriage the cause still remains uncertain. Thrombophilia has been identified in about 50% of women with recurrent miscarriage and thromboprophylaxis has been suggested as an option of treatment. A randomised double-blind (for aspirin) multicentre trial was performed among 207 women with three or more consecutive first trimester (* Trial registration number NCT0095962.This publication has 22 references indexed in Scilit:
- Body mass index and risk of miscarriage in women with recurrent miscarriageFertility and Sterility, 2010
- Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic reviewJournal of Thrombosis and Haemostasis, 2010
- Pregnancy outcome in women with factor V Leiden and recurrent miscarriageBJOG: An International Journal of Obstetrics and Gynaecology, 2009
- Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA TrialThe Journal of Rheumatology, 2009
- Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromePublished by Wiley ,2009
- RETRACTED ARTICLE: Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiologyJournal of Obstetrics and Gynaecology, 2008
- A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriagesFertility and Sterility, 2006
- Evidence-based investigations and treatments of recurrent pregnancy lossFertility and Sterility, 2005
- Epidemiology and the medical causes of miscarriageBest Practice & Research Clinical Obstetrics & Gynaecology, 2000
- Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin aloneAmerican Journal of Obstetrics and Gynecology, 1996